Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 131
News
News | 05 May 2022

Fear of fourth wave drives Indians to search Covid health services

Demand for pharmacies contribute to 52% of the total searches, vaccination centres 30%

News
News | 05 May 2022

Avantor to create a new manufacturing hub in Singapore

The new hub, which brings Avantor solutions closer to regional customers and strengthens global supply chain capabilities, will be fully operational early next year

News
News | 05 May 2022

Israeli researchers warn about the return of Delta variant

The research was supported by the BGU Coronavirus Challenge and the Israeli Ministry of Health.

News
News | 05 May 2022

Siemens Healthineers achieves milestone of producing 500 units of Cios Fit in India

Conceptualized, designed, and manufactured in India for the world, Cios Fit is a mobile C-arm designed for demanding multidisciplinary environments in busy operating rooms

News
News | 05 May 2022

Merck invests $110 million to expand production site in China

Company will expand the existing production site in Wuxi to significantly increase biopharma single-use assemblies and custom design capabilities

News
News | 05 May 2022

14.9 million excess deaths associated with the Covid-19 pandemic in 2020 and 2021

The report has estimated 4.74 million deaths for India in 2020 and 2021,

News
News | 04 May 2022

Eris Lifesciences acquires Oaknet Healthcare for Rs 650 crore

The deal will be financed by Rs 300 crore of internal accruals and Rs 350 crore of borrowings

News
News | 04 May 2022

India’s Drugs Controller General green lights trial of TRIA heart valve

The procedures have been performed by Dr. Kaushal Pandey at P.D. Hinduja Hospital in Mumbai, India

News
News | 04 May 2022

Pfizer sets up global drug development centre in Chennai

The facility is among 12 centres established worldwide, and the first in Asia

News
News | 02 May 2022

USFDA concludes inspection of Shilpa Medicare with four observations

The inspection was triggered by Shilpa's submission of applications for four ANDA's to seek approval to use this site as an alternate testing laboratory

News
News | 02 May 2022

Dr. Mansukh Mandaviya to chair a three-day health meet at Kevadia in Gujarat

State Ministers of Health and Medical Education to Participate in the meeting from 5th to 7th May

News
News | 01 May 2022

AstraZeneca’s new R&D Centre and Alexion HQ in Cambridge, Massachusetts

Move brings together AstraZeneca and Alexion colleagues in a purpose-built facility in Kendall Square, Cambridge, MA, a world-leading life sciences hub

News
News | 01 May 2022

India’s pharma exports grow by 103% since 2013-14

Pharma exports in 2021-22 sustain a positive growth despite global trade disruptions

News
News | 01 May 2022

GeneStore launches Centre of Excellence in Gurugram, India

Center of Excellence for Molecular Diagnostics and Proteomics will enable affordable diagnostics for infectious diseases in India

News
News | 29 April 2022

Ami Organics earmarks Rs 190 cr to expand API production in Ankleshwar

The plant is expected to start commercial operations from Q4FY24

News
News | 28 April 2022

Dr Vijay Shetty creates an alternative to x-ray examination

The procedure, named 'Shetty Test' after its creator, could change the way suspected fractures are treated

News
News | 28 April 2022

Beta Drugs announces oultook for FY 22-23

The management believes that its strong product pipeline, diversified innovative product portfolio, continued expansion into new geographies and FGMP accreditations will help sustain the growth momentum in the coming few years

News
News | 28 April 2022

Cipla bags Pharma Leader of the Year award

Glenmark Pharmaceuticals won Innovation of the Year award

News
News | 28 April 2022

Ross Prize awarded to mRNA technology, Covid-19 vaccine innovators

University of Pennsylvania scientists Katalin Karikó and Drew Weissman to be honoured at June 7 symposium in New York City for their research that enabled Covid-19 vaccines

News
News | 28 April 2022

Sanofi continues to deliver strong business

Business EPS of €1.94, up 20.5% on a reported basis and 16.1% at CER, also benefitting from an improved effective tax rate

Startup

Digitization